RLAY — Relay Therapeutics, Inc. stock price, charts and financials

QT62Relay Therapeutics, Inc.

Relay Therapeutics, Inc. (NASDAQ: RLAY) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
18.84
-0.35-1.82%
OverviewShort InterestFilings
RLAYQT62Relay Therapeutics, Inc.·NASDAQ
18.84-1.82%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Sep 09, 20264Statement of changes in beneficial ownership
Sep 09, 20264Statement of changes in beneficial ownership
Sep 09, 20264Statement of changes in beneficial ownership
Aug 28, 20264Statement of changes in beneficial ownership
Aug 28, 20264Statement of changes in beneficial ownership
Aug 18, 20264Statement of changes in beneficial ownership
Aug 18, 20264Statement of changes in beneficial ownership
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 10, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 07, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 06, 2026424B5Prospectus
Aug 06, 2026SC 13GBeneficial ownership statement (passive)
Aug 06, 202610-QQuarterly report
Aug 06, 20268-KCurrent report
Jul 30, 20264Statement of changes in beneficial ownership
Jul 30, 20264Statement of changes in beneficial ownership
Jul 30, 20264Statement of changes in beneficial ownership
Jul 08, 20264Statement of changes in beneficial ownership
Jul 08, 20264Statement of changes in beneficial ownership
Jul 08, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
#1 / 25 of 439
Page
▼
/ 18